PL328135A1 - Application of 1-centchromane enantiomer in production of a pharmaceutic agent for preventing or treating mammary cancers - Google Patents

Application of 1-centchromane enantiomer in production of a pharmaceutic agent for preventing or treating mammary cancers

Info

Publication number
PL328135A1
PL328135A1 PL97328135A PL32813597A PL328135A1 PL 328135 A1 PL328135 A1 PL 328135A1 PL 97328135 A PL97328135 A PL 97328135A PL 32813597 A PL32813597 A PL 32813597A PL 328135 A1 PL328135 A1 PL 328135A1
Authority
PL
Poland
Prior art keywords
centchromane
enantiomer
preventing
production
application
Prior art date
Application number
PL97328135A
Other languages
English (en)
Inventor
Michael Shalmi
Ved Prakash Kamboj
Omkar Prasad Asthana
Suprabhat Ray
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of PL328135A1 publication Critical patent/PL328135A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL97328135A 1996-01-11 1997-01-09 Application of 1-centchromane enantiomer in production of a pharmaceutic agent for preventing or treating mammary cancers PL328135A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1000096P 1996-01-11 1996-01-11
DK77696 1996-07-11
PCT/DK1997/000007 WO1997025034A1 (en) 1996-01-11 1997-01-09 Use of the l-enantiomer of centchroman for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of breast cancer

Publications (1)

Publication Number Publication Date
PL328135A1 true PL328135A1 (en) 1999-01-18

Family

ID=26064631

Family Applications (1)

Application Number Title Priority Date Filing Date
PL97328135A PL328135A1 (en) 1996-01-11 1997-01-09 Application of 1-centchromane enantiomer in production of a pharmaceutic agent for preventing or treating mammary cancers

Country Status (12)

Country Link
EP (1) EP0873119A1 (ko)
JP (1) JP2001500101A (ko)
KR (1) KR19990077157A (ko)
AU (1) AU1367197A (ko)
BR (1) BR9706966A (ko)
CA (1) CA2241462A1 (ko)
CZ (1) CZ217198A3 (ko)
HU (1) HUP9901633A3 (ko)
IL (1) IL124881A0 (ko)
NO (1) NO983177L (ko)
PL (1) PL328135A1 (ko)
WO (1) WO1997025034A1 (ko)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1028724A1 (en) * 1997-11-10 2000-08-23 Novo Nordisk A/S Transdermal delivery of 3,4-diarylchromans
US6465445B1 (en) 1998-06-11 2002-10-15 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
AU2004200099B2 (en) * 1998-06-11 2006-11-02 Endorecherche, Inc. Medical Uses of A Selective Estrogen Receptor Modulator in Combination with Sex Steroid Precursors
AU2011253842B2 (en) * 1998-06-11 2014-08-14 Endorecherche Inc. Medical Uses of a Selective Estrogen Receptor Modulator in Combination with Sex Steroid Precursors
US7005428B1 (en) 1998-06-11 2006-02-28 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
CN106038572A (zh) 2004-10-20 2016-10-26 恩多研究公司 性甾体前体单独或与选择性雌激素受体调节剂联合用于预防和治疗绝经后女性的性功能障碍
US8268806B2 (en) 2007-08-10 2012-09-18 Endorecherche, Inc. Pharmaceutical compositions
MX2010004195A (es) 2007-10-16 2010-06-02 Repros Therapeutics Inc Trans-clomifeno para el sindrome metabolico.
US20100317635A1 (en) 2009-06-16 2010-12-16 Endorecherche, Inc. Treatment of hot flushes, vasomotor symptoms, and night sweats with sex steroid precursors in combination with selective estrogen receptor modulators
SG186333A1 (en) 2010-06-16 2013-01-30 Endorech Inc Methods of treating or preventing estrogen-related diseases
MX2014009322A (es) 2012-02-29 2014-11-10 Repros Therapeutics Inc Terapia de combinacion para el tratamiento de la deficiencia androgenica.
US9744177B2 (en) 2014-03-10 2017-08-29 Endorecherche, Inc. Treatment of male androgen deficiency symptoms or diseases with sex steroid precursor combined with SERM
US11633382B2 (en) 2015-11-10 2023-04-25 Paracrine Therapeutics Ab Treatment of ER-negative breast cancer with an PDGF-CC inhibitor and anti-estrogen

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4447622A (en) * 1981-09-22 1984-05-08 Council Of Scientific And Industrial Research Rafi Marg Preparation of l- and d-isomers of dl-3,4-trans-2,2-disubstituted-3,4-diarylchromans and derivatives thereof

Also Published As

Publication number Publication date
NO983177L (no) 1998-07-10
BR9706966A (pt) 1999-05-04
HUP9901633A3 (en) 2000-02-28
JP2001500101A (ja) 2001-01-09
IL124881A0 (en) 1999-01-26
AU1367197A (en) 1997-08-01
HUP9901633A2 (hu) 1999-10-28
KR19990077157A (ko) 1999-10-25
CA2241462A1 (en) 1997-07-17
EP0873119A1 (en) 1998-10-28
WO1997025034A1 (en) 1997-07-17
CZ217198A3 (cs) 1998-11-11

Similar Documents

Publication Publication Date Title
EP0718099A3 (de) Präge-Rotationsmaschine
PL323128A1 (en) Application of heterocyclic compounds in production of a pharmaceutic agent, novel heterocyclic compounds and pharmaceutic agent as such
PL323130A1 (en) Application of heterocyclic compounds in production of a pharmaceutic agent, novel heterocyclic compounds and pharmaceutic agent as such
GB9801231D0 (en) A method of treating cancer
EP1075533A4 (en) SMALL MOLECULE ANTICANCER COMPOUNDS AND METHODS FOR PRODUCING THE SAME
GB2325421B (en) Process for coating surgical needles
EP0742849A4 (en) SURFACE TREATMENT AGENT FOR ZINC PLATED STEEL
HU9700793D0 (en) High-pressure treated starch
PL327505A1 (en) Production of biscyclopentadienylodiene complexes
GB9614476D0 (en) Rotary machine
HUP9601972A3 (en) Rotary machine
CZ71095A3 (en) Track ballastway treating machine
EP1007041A4 (en) COMPOSITION FOR TREATING PAIN
GB2323057B (en) Finishing machine for foil and plate manufacture
GB2294646B (en) Material treatment
CZ72895A3 (en) Track ballastway treating machine
GB2322151B (en) Synthetic surface treatment apparatus
HU9601450D0 (en) Process for producing pharmaceutical composition for treating neoplasmic syndromas
GB9402665D0 (en) Tunnelling machine
SG101918A1 (en) Tableting process and tableting machine
GB9704073D0 (en) Lyocell fabric treatment
HU9400631D0 (en) Process for treating tumors
TW360431U (en) Apparatus for rotation generating pattern
ZA957729B (en) Block making machine
PL301998A1 (en) Rotary machine